MA-ALIRA-HEALTH
Alira Health (http://www.alirahealth.com/ ), a global health care consultancy, announced that it has acquired Patchai, a digital health technology company headquartered in Italy. Patchai offers intelligent digital health solutions that engage and empower patients in clinical research and care pathways, enabling better self-management of their health conditions, improving adherence to study protocols and care plans, while facilitating care delivery for clinicians with robust, real-time data. Patchai’s Co-PRO® suite of technologies personalizes patient experience, ensuring high patient satisfaction and retention in decentralized clinical trials. This is Alira Health’s second digital health acquisition, furthering the company’s rapid expansion into patient-centric, technology-enabled solutions for healthcare providers, payers, and suppliers.
“Alira Health is investing heavily in the use of technology to boost patient engagement, improve clinical trials, and collect and apply valuable real-world evidence. We are committed to humanizing health care through innovative, patient-centric technology solutions. Our acquisition of Patchai is a strategic step in realizing our vision of being the market leader in technology used for the collection of patient data in real world studies,” said Gabriele Brambilla, Co-Founder and CEO of Alira Health.
“Patchai’s mission is to advance life sciences with intelligent and human-centered solutions to channel and magnify the positive impact that bio-pharmaceutical companies, healthcare professionals and patients have on the future of health systems," said Alessandro Monterosso, Co-Founder and CEO of Patchai. “We are extremely pleased to join Alira Health and be part of their mission to transform healthcare globally by engaging patients at every step of their journey.”
Patchai has developed an intelligent platform embedding an empathetic virtual companion to deliver personalized human centric interactions to patients and collect Real World Data in real time. Preliminary data on patients using Patchai technology shows a patients’ protocol adherence up to 95%, significantly higher than other digital solutions on the market today and up to nine times higher than paper-based solutions. Patchai was accelerated by Plug and Play Tech Center in Silicon Valley and was finalist at the Catapult Awards, one of the flagship programs of EIT Health. The company, now part of Alira Health, will continue to advance its technologies to offer scalable and modular solutions for Decentralized Clinical Research and Virtual standard care.
About Patchai
Founded in 2018, Patchai’s vision is to make clinical research and routine care more engaging, smart and accessible to improve people’s quality of life. Patchai developed an intelligent platform for patient engagement and real-time data capture in decentralized clinical research and standard care. It enables clinical research and standard clinical practice to become more humane, connected and streamlined. In 2021, Patchai has been included in the Global Top 100 Digital Health Companies by The Medical Futurist Institute.
Learn more at www.patchai.io .
About Alira Health:
Alira Health is an international patient-centric and technology-enabled advisory firm on the frontlines of healthcare transformation. We provide a suite of integrated services designed to help healthcare and life science companies innovate and grow across their solutions lifecycle.
Alira Health was founded in 1999 and is based in Framingham, MA, U.S. Alira Health has offices in San Francisco, CA, U.S.; Paris, France; Barcelona, Spain; Munich, Germany; Milan, Bologna and Verona, Italy; Basel, Switzerland; and Cambridge, UK.
Learn more at www.alirahealth.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211116005047/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Neural Concept Closes $100M Funding Round Led by Growth Equity at Goldman Sachs Alternatives to Scale AI-Native Engineering18.12.2025 17:00:00 CET | Press release
New capital accelerates Neural Concept’s ability to deliver transformative technologies and enterprise-wide AI impact across advanced industrial workflows.Platform delivers CAD-native, physics-aware AI and deep reasoning for engineering, saving customers $50 million annually, reducing late-stage redesigns by 30-50% and accelerating time to market by up to two years.The company has generated a fourfold increase in enterprise revenue over the past 18 months.More than 50 global companies are actively relying on the platform, including General Motors, General Electric Vernova, Leonardo Aerospace, Eaton, Safran, Renault Group and multiple Formula 1 teams. Neural Concept, a global AI platform and leader in Engineering Intelligence powering next-generation product development, today announced it raised a $100 million Series C funding round led by Growth Equity at Goldman Sachs Alternatives, with existing investors Forestay Capital, Alven, HTGF, D.E. Shaw Ventures and Aster Capital. This press
Croma-Pharma Introduces New Medical Device for the Preparation of Autologous PRP | Fluid- PRF18.12.2025 16:57:00 CET | Press release
Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for the preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin (Fluid-PRF).1 This launch represents continued progress in Croma’s mission to provide healthcare professionals state-of-the-art tools for their practice. With its innovative design and optimized separation technology, Exprecell™ enables the efficient preparation of autologous blood concentrates, without the use of anticoagulants, resulting in the formation of Fluid-PRF, a biologically active concentrate that retains the regenerative properties of platelets and leukocytes, yet stays liquid for a defined period.1 What makes Exprecell™ special?MDR certification: Exprecell™ is MDR-certified, meeting stringent EU regulatory requirements to ensure the safe, controlled and standardized preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin
Laserfiche is a Leader in Info-Tech Research Group’s Enterprise Content Management - Enterprise Data Quadrant18.12.2025 16:00:00 CET | Press release
AI-driven document management and process automation position Laserfiche highest for Product Features and Satisfaction. Laserfiche — the leading SaaS provider of intelligent content management and business process automation — is a Leader in the Enterprise Content Management – Enterprise Data Quadrant Report from Info-Tech Research Group. With the most reviews of any vendor and a composite score of 9.1, Laserfiche was positioned highest for Product Features and Satisfaction. “Laserfiche is honored to be recognized as a Leader in the ECM Data Quadrant at a moment when AI is transforming every aspect of how organizations create value from their data,” said Thomas Phelps IV, CIO and SVP of corporate strategy at Laserfiche. “We’re especially appreciative of the more than 400 reviews contributing to our +94 net emotional footprint and the 99% of users who indicate ‘they love the Laserfiche platform.’” The Info-Tech Data Quadrant evaluates and ranks products, capabilities and features based
Interactive Brokers Redesigns IBKR GlobalTrader App for Simpler, Smarter Mobile Trading18.12.2025 16:00:00 CET | Press release
New mobile experience offers faster navigation, AI-driven market insights, and integrated access to forecast contracts for investors worldwide Interactive Brokers (Nasdaq: IBKR), an automated global electronic broker, today announced the launch of its redesigned IBKR GlobalTrader mobile app. The updated trading platform reflects the firm’s commitment to delivering intuitive, accessible tools for investors at every experience level. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218345494/en/ IBKR GlobalTrader The new version offers a faster and more powerful interface with new capabilities, including integrated access to forecast contracts, AI-generated news summaries, and a redesigned Explore section that helps investors identify opportunities across global markets. Investors can trade stocks, ETFs, options, access cryptocurrencies, and more – all from a streamlined mobile app. IBKR GlobalTrader complements IBKR Mobile,
The Rock-It Company Appoints David Byrnes as Chief Financial Officer18.12.2025 15:00:00 CET | Press release
Entertainment and media veteran joins as The Rock-It Company embarks on a new chapter of global growth and acceleration The Rock-It Company, the global leader in specialty logistics across live events and luxury goods, announced today the appointment of David Byrnes as Chief Financial Officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218600008/en/ David Byrnes, Chief Financial Officer, The Rock-It Company With decades of experience steering groundbreaking multimedia and live experience projects globally, David joins The Rock-It Company from Sphere Entertainment, where he most recently served as Executive Vice President and Chief Financial Officer. His career includes multiple senior leadership roles, including CFO of Madison Square Garden Entertainment Corp., Executive Vice President of Corporate Finance at Paramount, and a variety of senior leadership positions at CBS Corporation. He also spent five years at ADP, i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom